Every researcher knows the frustration: your groundbreaking experiment is on hold because the DNA sequence you need is "unmanufacturable". Or worse, after weeks of waiting, the oligos arrive with ...

According to a recent report by Market.us, the Global DNA Microarray Market size is expected to be worth around USD 4,593.7 Million by 2033 from USD 1,994.6 Million in 2023, growing at a CAGR of 8.7% ...

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

Elegen’s ENFINIA™ Linear DNA offers high-accuracy, double-stranded DNA up to 7kb with 99.999% accuracy. Its cell-free synthesis eliminates cloning, delivering NGS-verified sequences in 6–8 business ...

Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...

There’s an old saying about a dollar waiting on a dime. In other words, a monumental endeavor may become stuck at some point if a key preliminary element remains unavailable. The saying could be ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis ...

Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS & DALY CITY, Calif.--(BUSINESS WIRE)--DNA ...

The COVID-19 pandemic thrust messenger RNA (mRNA) into the spotlight, underscoring its promise as a nimble, programmable platform for delivering genetic instructions directly to cells. The success of ...